InvestorsHub Logo

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Live Updating
profile icon
Monksdream PremiumMember
03/06/24 1:31 PM
profile icon
mick Grandfathered
07/09/23 5:47 PM
profile icon
mick Grandfathered
06/25/23 12:27 PM
profile icon
mick Grandfathered
05/29/23 5:50 PM
profile icon
mick Grandfathered
04/30/23 5:05 PM
Bullish
Bullish
profile icon
mick Grandfathered
04/15/23 11:05 AM
Bullish
Bullish
profile icon
mick Grandfathered
02/26/23 7:02 PM
profile icon
mick Grandfathered
02/05/23 7:10 PM
profile icon
mick Grandfathered
02/05/23 7:10 PM
profile icon
lowfloatwayne Terminated
01/22/23 4:17 PM
profile icon
Sesh Free
01/04/23 2:27 AM
profile icon
mick Grandfathered
12/18/22 5:53 PM
profile icon
mick Grandfathered
10/23/22 2:22 PM
profile icon
mick Grandfathered
08/31/22 7:32 PM
profile icon
BooDog Free
08/25/22 2:11 PM
profile icon
mick Grandfathered
08/25/22 1:57 PM
profile icon
mick Grandfathered
08/25/22 1:55 PM
profile icon
mick Grandfathered
08/25/22 1:52 PM
profile icon
mick Grandfathered
08/25/22 1:52 PM
profile icon
BooDog Free
08/25/22 7:11 AM
profile icon
mick Grandfathered
07/17/22 6:10 PM
profile icon
mick Grandfathered
07/17/22 6:10 PM
profile icon
carldfw Free
06/09/22 3:00 PM
profile icon
carldfw Free
06/09/22 3:00 PM
profile icon
mick Grandfathered
06/05/22 1:51 AM
profile icon
mick Grandfathered
05/01/22 4:06 PM
profile icon
crudeoil24 PremiumMember
04/25/22 6:57 AM
profile icon
mick Grandfathered
03/12/22 2:22 PM
profile icon
mick Grandfathered
02/05/22 5:45 PM
profile icon
mick Grandfathered
11/06/21 12:48 PM
profile icon
mick Grandfathered
09/22/21 7:44 PM
profile icon
mick Grandfathered
08/14/21 4:04 PM
profile icon
Richard2 Free
07/30/21 8:32 PM
profile icon
carldfw Free
07/24/21 6:29 PM
profile icon
swampboots PremiumMember
07/20/21 8:51 PM
profile icon
carldfw Free
07/17/21 8:31 PM
profile icon
mick Grandfathered
07/10/21 10:57 PM
profile icon
carldfw Free
06/27/21 5:29 PM
profile icon
mick Grandfathered
06/26/21 10:48 AM
profile icon
carldfw Free
06/25/21 9:12 PM

AIM ImmunoTech Inc (AIM) RSS Feed

Followers
57
Posters
206
Posts (Today)
0
Posts (Total)
2072
Created
04/27/12
Type
Free
Moderators



 

About AIM ImmunoTech

 
 

AIM ImmunoTech Inc. is an immuno-pharma company headquartered in Ocala, Florida and focused on the research and development of therapeutics to treat multiple types of cancers,
as well as immune-deficiency disorders. We have established a strong foundation of laboratory, pre-clinical and clinical data with respect to the development of nucleic acids
and natural interferon to enhance the natural antiviral defense system of the human body and to aid the development of therapeutic products for the treatment of certain cancers and chronic diseases.

AIM ImmunoTech’s flagship products include Ampligen® (Rintatolimod), a first-in-class drug of large macromolecular RNA (ribonucleic acid) molecules, and Alferon N Injection® (Interferon Alfa-N3).
Ampligen® represents an RNA being developed for globally important cancers, viral diseases and disorders of the immune system.
Ampligen® is also being evaluated for the treatment of myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS).
Alferon N Injection® is approved for a category of STD infection and patients that are intolerant to recombinant interferon in Argentina.
Alferon is the only natural-source, multi-species alpha interferon currently approved for sale in the U.S. for the intralesional treatment of refractory (resistant to other treatment)
or recurring external Condylomata Acuminata/genital warts (GW) in patients 18 years of age or older.

We operate a 30,000 sq. ft. facility in New Brunswick, NJ with the objective of producing Ampligen® and Alferon®.
We are committed to a focused business plan oriented toward finding senior co-development partners with the capital and
expertise needed to commercialize the many potential therapeutic aspects of Ampligen® and our FDA-approved drug Alferon® N.

https://aimimmuno.com/blog/

CEO Roadshow Interviews Hemispherx Thomas K. Equels

April 4th, 2019

CEO Roadshow Interviews Hemispherx Thomas K. Equels Hemispherx CEO Thomas K. Equels recently sat down with Mike Elliot of CEO Roadshow to provide an update on everything the company is working at [...]

IM ImmunoTech Reaches Deal with Japan’s National Institute of Infectious Diseases to Test Ampligen as a Potential Treatment for Coronavirus

Introducing You to the First Ampli